Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

CENTRE SPECIALITES EXPORT PHARMA : revenue, balance sheet and financial ratios

CENTRE SPECIALITES EXPORT PHARMA is a French company founded 31 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in SAINT-BEAUZIRE (63360), this company of category PME shows in 2023 a net income negative of -902 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CENTRE SPECIALITES EXPORT PHARMA (SIREN 398785816)
Indicator 2023 2022 2018 2017 2016
Revenue N/C N/C N/C N/C N/C
Net income -902 206 € 164 655 € 486 002 € 420 631 € 603 678 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, CENTRE SPECIALITES EXPORT PHARMA records a net loss of 902 k€. This deficit will reduce equity on the balance sheet.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-902 206 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 68%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

68.19%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

54.821%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

43.6%

Solvency indicators evolution
CENTRE SPECIALITES EXPORT PHARMA

Sector positioning

Debt ratio
68.19 2023
2018
2022
2023
Q1: 0.0
Med: 5.57
Q3: 50.77
Average

In 2023, the debt ratio of CENTRE SPECIALITES EXPORT... (68.19) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
54.82% 2023
2018
2022
2023
Q1: 13.47%
Med: 38.42%
Q3: 58.45%
Good +11 pts over 3 years

In 2023, the financial autonomy of CENTRE SPECIALITES EXPORT... (54.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1321.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1321.257

Liquidity indicators evolution
CENTRE SPECIALITES EXPORT PHARMA

Sector positioning

Liquidity ratio
1321.26 2023
2018
2022
2023
Q1: 133.58
Med: 205.53
Q3: 329.15
Excellent

In 2023, the liquidity ratio of CENTRE SPECIALITES EXPORT... (1321.26) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of CENTRE SPECIALITES EXPORT PHARMA in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare CENTRE SPECIALITES EXPORT PHARMA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about CENTRE SPECIALITES EXPORT PHARMA

What is the revenue of CENTRE SPECIALITES EXPORT PHARMA ?

The revenue of CENTRE SPECIALITES EXPORT PHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is CENTRE SPECIALITES EXPORT PHARMA profitable?

CENTRE SPECIALITES EXPORT PHARMA recorded a net loss in 2023.

Where is the headquarters of CENTRE SPECIALITES EXPORT PHARMA ?

The headquarters of CENTRE SPECIALITES EXPORT PHARMA is located in SAINT-BEAUZIRE (63360), in the department Puy-de-Dome.

Where to find the tax return of CENTRE SPECIALITES EXPORT PHARMA ?

The tax return of CENTRE SPECIALITES EXPORT PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CENTRE SPECIALITES EXPORT PHARMA operate?

CENTRE SPECIALITES EXPORT PHARMA operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.